Arcadia Biosciences (RKDA) Tops Q2 EPS by 78c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.78. Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections